Screener
Adaptive Biotechnologies ADPT Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206546
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Current portion of revenue interest liability, net | 5,804 | 4,642 |
| Total current liabilities | 87,011 | 89,915 |
| Long-term liabilities | ||
| Operating lease liabilities, less current portion | 69,115 | 70,228 |
| Deferred revenue, less current portion | 807 | 1,006 |
| Revenue interest liability, net, less current portion | 124,749 | 126,566 |
| Other long-term liabilities | 20 | 20 |
| Total liabilities | 281,702 | 287,735 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Adaptive Biotechnologies's operating lease liabilities?
- Adaptive Biotechnologies (ADPT) reported operating lease liabilities of $69.12M in Q1 2026.
- How has Adaptive Biotechnologies's operating lease liabilities changed year-over-year?
- Adaptive Biotechnologies's operating lease liabilities decreased by 9.6% year-over-year, from $76.44M to $69.12M.
- What is the long-term trend for Adaptive Biotechnologies's operating lease liabilities?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's operating lease liabilities has grown at a -7.6% compound annual growth rate (CAGR), from $104.33M to $70.23M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Adaptive Biotechnologies's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude